Neoloba Specialty Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-11-2024
- Paid Up Capital ₹ 4.10 M
as on 17-11-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
as on 17-11-2024
- Revenue 333.72%
(FY 2023)
- Profit -11.86%
(FY 2023)
- Ebitda 23.58%
(FY 2023)
- Net Worth 13.24%
(FY 2023)
- Total Assets 311.44%
(FY 2023)
About Neoloba Specialty
The Corporate was formerly known as Innovative Organochem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.10 M.
The company currently has active open charges totaling ₹5.00 Cr.
Rushabh Sheth, Nikhil Shah, Shreans Daga, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100MH2015PTC261019
- Company No.
261019
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2015
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Neoloba Specialty?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rushabh Sheth  | Director | 18-Apr-2022 | Current |
| Nikhil Shah | Director | 18-Apr-2022 | Current |
| Shreans Daga | Director | 18-Apr-2022 | Current |
| Darshak Upadhyay | Director | 15-Jul-2022 | Current |
Financial Performance of Neoloba Specialty.
Neoloba Specialty Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 333.72% increase. The company also saw a substantial fall in profitability, with a 11.86% decrease in profit. The company's net worth Soared by an impressive increase of 13.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neoloba Specialty?
In 2023, Neoloba Specialty had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Sep 2022 | ₹5.00 Cr | Open |
How Many Employees Work at Neoloba Specialty?
Neoloba Specialty has a workforce of 34 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neoloba Specialty, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neoloba Specialty's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
